Hosted on MSN1h
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay
The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...
Researchers develop targeted treatment for aggressive pregnancy cancer
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...
Science Daily5h
Researchers find improved method for treating rare, aggressive, pregnancy-related cancer
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...